Silverback Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $41k | 7.5k | 5.48 |
| 2023-09-30 | $22k | 5.9k | 3.78 |
| 2023-06-30 | $64k | 9.5k | 6.70 |
| 2022-12-31 | $2.0k | 236 | 8.53 |
| 2022-09-30 | $999 | 152 | 6.58 |
| 2022-06-30 | $1.0k | 148 | 6.76 |
| 2022-03-31 | $13k | 4.2k | 3.08 |
| 2021-12-31 | $57k | 8.5k | 6.69 |
| 2021-09-30 | $0 | 17k | 0.00 |
| 2021-06-30 | $18k | 588 | 30.73 |
| 2021-03-31 | $192k | 4.4k | 43.70 |